ACS Omega · 2019 · 32 citations · 47 references
EngineeringBioengineeringBiomedical EngineeringBiomaterialsDrug DeliveryTissue EngineeringAngiogenesisDrug Delivery BiomaterialsGrowth Factor DeliveryGrowth Factor Delivery SystemsPolymeric Drug Delivery SystemsTissue Engineering ScaffoldsAngiogenic Delivery SystemsLocal Sustained Release Delivery SystemsMicrosphere Delivery SystemsMicrospheresSynthetic ScaffoldsSynthetic Tissue ScaffoldsVascular Endothelial Growth FactorVascularization
-[PLLA])-based multiblock copolymers with different PEG content and PEG molecular weight were used to prepare the microspheres. Loading of the microspheres was established by a solvent evaporation-based membrane emulsification method. The resulting VEGF-loaded microspheres had average sizes of 40-50 μm and a narrow size distribution. Optimized formulations of a 50:50 blend of the two multiblock copolymers had an average VEGF loading of 0.79 ± 0.09%, representing a high average VEGF loading efficiency of 78 ± 16%. These microspheres released VEGF continuously over 4 weeks in phosphate-buffered saline pH 7.4 at 37 °C. This release profile was preserved after repeated and long-term storage at -20 °C for up to 9 months, thereby demonstrating excellent storage stability. VEGF release was governed by diffusion through the water-filled polymer matrix, depending on PEG molecular weight and PEG content of the polymers. The bioactivity of the released VEGF was retained within the experimental error in the 4-week release window, as demonstrated using a human umbilical vein endothelial cells proliferation assay. Thus, the microspheres prepared in this study are suitable for embedment in polymeric scaffolds with the aim of promoting their functional vascularization.
47